Security key
29446K106
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)
CUSIP: 29446K106
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 66,704,586
- Total 13F shares
- 8,889,978
- Share change
- -587,693
- Total reported value
- $20,532,946
- Put/Call ratio
- 0.56%
- Price per share
- $2.31
- Number of holders
- 27
- Value change
- -$656,679
- Number of buys
- 13
- Number of sells
- 14
Report period
Q1 2024
Institutions
27
Top holders
10
EQ full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Equillium, Inc. SEC filings
Equillium, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29446K106
Recent filing periods:
Top shareholders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Decheng Capital LLC |
13F
|
Company |
6.7%
|
4,447,308
|
$3,215,403 | — | 31 Dec 2023 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
2.7%
|
1,824,977
|
$1,313,983 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
836,930
|
$605,100 | — | 31 Dec 2023 | |
| Cota Capital Management, LLC |
13F
|
Company |
0.84%
|
562,278
|
$406,527 | — | 31 Dec 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
400,000
|
$289,200 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.52%
|
350,031
|
$253,072 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.52%
|
347,500
|
$251,000 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
172,387
|
$124,660 | — | 31 Dec 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.15%
|
100,000
|
$72,000 | — | 31 Dec 2023 | |
| Callan Capital, LLC |
13F
|
Company |
0.15%
|
99,688
|
$72,074 | — | 31 Dec 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.1%
|
65,400
|
$47,284 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
62,999
|
$45,548 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
56,220
|
$40,647 | — | 31 Dec 2023 | |
| Integrated Wealth Concepts LLC |
13F
|
Company |
0.06%
|
40,000
|
$28,920 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
35,155
|
$25,417 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
24,692
|
$17,852 | — | 31 Dec 2023 | |
| Capital CS Group, LLC |
13F
|
Company |
0.03%
|
19,000
|
$13,737 | — | 31 Dec 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
12,040
|
$8,705 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
9,382
|
$6,783 | — | 31 Dec 2023 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.01%
|
6,500
|
$4,700 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
3,823
|
$2,764 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,149
|
$831 | — | 31 Dec 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
200
|
$145 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
12
|
$9 | — | 31 Dec 2023 | |
| Joel Rothman |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
233,150
mixed-class rows
|
$33,727 | — | 02 Jan 2024 |
Institutional Holders of Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) as of Q1 2024
As of 31 Mar 2024,
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,889,978 shares.
The largest 10 holders included
Decheng Capital LLC, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, Cota Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ADAR1 Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, Callan Capital, LLC, and STATE STREET CORP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
24
Q1 2024 holders
27
Holder diff
3
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.